Skip to main content
Clinical Trials/CTRI/2021/07/034606
CTRI/2021/07/034606
Completed
Phase 4

A clinical study to evaluate the role of Ayurveda medicines in Preventing COVID-19 infections

Sree Ramachandra Health services Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Sree Ramachandra Health services Pvt Ltd
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Sree Ramachandra Health services Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\.People not vaccinated with any COVID Vaccine at the time of enrolment in the trial.
  • 2\.Age limit â?? 18 to 45 years, both Male \& Female
  • 3\.Patients willing to give their consent to participate in the clinical trial

Exclusion Criteria

  • 1\.People vaccinated with any Covid vaccine at any point of time before enrolment in the trial.
  • 2\.People with PCR proven Covid infections within the last 3 months
  • 3\.People taking other Ayurvedic/ Siddha medicines.
  • 4\.Patients with acute renal failure or Stage 4 CKD or Liver Failure (AST/ALT \>5 times elevated)
  • 5\.Patients on Immuno\-suppression therapy
  • 6\.Pregnant Women or lactating mothers

Outcomes

Primary Outcomes

Not specified

Similar Trials